 |
Corporate News
26-Apr-22
|
|
|
|
|
|
|
|
|
|
|
|
Biocon Biologics secures 3-year contract from Ministry of Health, Malaysia
|
|
For supply of its range of insulin 'Insugen'
|
|
|
|
|
|
Biocon Biologics, a subsidiary of Biocon, announced that its subsidiary Biocon Sdn. Bhd. in Malaysia has been awarded a three-year contract valued at USD 90 million for its recombinant human insulin brand Insugen, by the Ministry of Health, Malaysia.
Biocon Sdn. Bhd. will manufacture and supply its range of insulins to its partners Duopharma Marketing Sdn. Bhd., a subsidiary of Duopharma Biotech, a leading pharmaceutical and biotech company in Malaysia.
Biocon Biologics' Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics.
|
|
|
|
Previous News |
Indices trade with decent gains; realty shares rallied for 5th day
(
Market Commentary
-
Mid-Session
17-May-24
12:40
)
|
|
|
Biocon arm inks pact to launch biosimilar Bmab 1200 in multiple countries
(
Hot Pursuit
-
29-Aug-24
12:21
)
|
|
|
Biocon Ltd soars 1.22%, rises for fifth straight session
(
Hot Pursuit
-
27-Mar-24
13:00
)
|
|
|
Biocon Ltd up for fifth session
(
Hot Pursuit
-
22-Aug-24
13:00
)
|
|
|
Biocon Ltd up for third consecutive session
(
Hot Pursuit
-
11-Sep-24
13:06
)
|
|
|
Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
(
Hot Pursuit
-
24-Jun-24
09:34
)
|
|
|
Biocon AGM scheduled
(
Corporate News
-
17-May-24
13:47
)
|
|
|
Biocon consolidated net profit declines 29.78% in the June 2023 quarter
(
Results
-
Announcements
11-Aug-23
07:47
)
|
|
|
Biocon Ltd soars 1.18%, Gains for third straight session
(
Hot Pursuit
-
26-Dec-23
13:05
)
|
|
|
Biocon Ltd spurts 2.7%, up for third straight session
(
Hot Pursuit
-
05-Apr-23
13:05
)
|
|
|
Biocon gains after arm inks distribution agreement with Sandoz
(
Hot Pursuit
-
26-Dec-23
10:40
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|